During ICI, gene expression xCell analyses of circulating immune cells of the patient, showed a progressive normalization of the total immune profile, with significant boost in CD4<sup>+</sup> and CD8<sup>+</sup> T cells and a reduction in NK T, comparable to the circulating immune profile of reference tumor-free HNSCC patients. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.